Business Context and Reporting Period
Company: NeuroOne Medical Technologies Corp (NMTC)
Filing Type: Form 8-K (Current Report)
Date of Report: April 30, 2026
Reporting Period: The filing addresses a specific event regarding Nasdaq listing compliance resolved on April 30, 2026.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on regulatory compliance status.
Material Changes
- Regulatory Status Change: The Company resolved a deficiency regarding the Nasdaq Listing Rule 5550(a)(2) (Minimum Bid Price Requirement).
- Previous Deficiency: On May 6, 2025, the Company received a notice that its closing bid price was below $1.00 per share for 30 consecutive business days.
- Resolution: As of April 30, 2026, the Company regained compliance after maintaining a closing bid price of $1.00 per share or greater for 10 consecutive business days.
- Outcome: The Nasdaq Staff confirmed the matter is closed and the Company is in compliance.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the successful restoration of compliance with Nasdaq listing standards. No forward-looking guidance, financial outlook, or new risk factors were disclosed in this report.
Unusual Items: None reported beyond the resolution of the prior bid price deficiency.
Investor Verification Checklist
- Verify the current trading price of NMTC common stock on the Nasdaq Capital Market to ensure continued compliance with the $1.00 minimum bid price rule.
- Review the Company's most recent 10-K or 10-Q filings for financial performance data, as this 8-K contains no financial metrics.
- Monitor future Nasdaq communications to ensure no new listing deficiencies arise.